Latha Vairavan, the Senior Vice President and Chief Financial Officer of Arcutis Biotherapeutics, has executed a sale of company stock valued at $9,156. This transaction is part of her financial management activities and reflects standard practices among executives in publicly traded companies. Details regarding the specific number of shares sold and the timing of the transaction have not been disclosed.
Related Articles
Don't miss out on breaking stories and in-depth articles.